Living with Hypertension: A Qualitative Research.
Afzal Shamsi, Nahid Dehghan Nayeri, Maryam Esmaeili
PMID 28670584WHAT IT FOUND
Hypertensive patients described fear of recurrence, family and financial strain, sexual and spiritual worries, and mixed views of medication.
Some stopped drugs due to side effects or dependence fears, so ask about these barriers.
Key findings
01The 27 Iranian patients described three main categories: disease shadow, dual understanding of drug therapy, and facing the disease.
02Patients reported mixed medication experiences: regular use helped when symptoms or complications were severe, while side effects and dependence fears led some to stop or reduce drugs.
03Family support, lifestyle change and spirituality were common coping strategies, but some patients denied hypertension's seriousness and used herbs instead of prescribed medicines.
STILL TO COME
How it was doneWhat they foundWhat it means for RNs
Read the rest of this summary
You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.
What it does not show
Qualitative themes describe experiences and barriers, not tested interventions or blood-pressure outcomes. The sample was 27 adults from Tehran medical centers, so the cultural and social context may not fit other populations. Participants had hypertension for at least two years and cognitive or mental illness was excluded, so the findings may not reflect newly diagnosed patients or those with cognitive or psychiatric conditions. Long-standing hypertension was linked to problems remembering experiences, and relatives were used to help overcome this. The authors reported no similar Iranian studies for comparison.
Declared interests
The supplied text does not report conflicts or funding. It states that the study was a nursing doctoral thesis.
The easy way to misread this
Do not read these themes as evidence that any intervention controls blood pressure. They describe patients' experiences and adherence barriers in one Iranian sample, not tested treatments.